The incidence and clinical impact of bone metastases in non-small cell lung cancer
Michael Kuchuk(University of Ottawa), Paul Wheatley‐Price(University of Ottawa), Elham Sabri(Ottawa Hospital), Brian Hutton(Ottawa Hospital), Iryna Kuchuk(University of Ottawa), Mark Clemons(Ottawa Hospital)
Cited by 117
Related Papers
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
|Annals of Internal Medicine|2015|8.2k
Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial
|The Lancet Oncology|2018|1k
Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study
|The Lancet Oncology|2018|579
Age of Transfused Blood in Critically Ill Adults
|New England Journal of Medicine|2015|559
Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias
|The Lancet Neurology|2020|535